Navigation Links
Unfavourable Lipid-Lipoprotein profiles in older adults has been linked to abdominal visceral fat

According to investigators from the Department of Human Services at the University of Virginia, in persons over 60 years of age, elevated levels of abdominal visceral fat are associated with unfavourable plasma concentrations of lipids and lipoproteins. Abdominal fat was also found to be a primary determinant in the release of growth hormone in these individuals. The investigators assessed// plasma lipids and lipoproteins and their relationships to abdominal visceral fat, fat mass, growth hormone release, fitness and also insulin and glucose concentrations in 19 women and 31 men over the age of 60. The subjects were divided into groups based on high or low abdominal visceral fat, fat mass and abdominal visceral fat corrected for fat mass.

The researchers found that there were differences in very-low-density lipoprotein (VLDL), triglycerides (TG), VLDL-TG, apo-B, apo-B LDL and high-density lipoprotein (HDL) and HDL(2) among the two groups. They also found that women had higher cholesterol, LDL, HDL and HDL(2). Fasting insulin was related to lipids and lipoproteins in both women and men and growth hormone and fitness were both related to lipoprotein and cholesterol levels with some specific differences observed between genders.


'"/>




Page: 1

Related medicine news :

1. Personality profiles of gamblers and substance abusers are similar
2. Acoustic neuroma in older patients to be treated
3. Quality of lives of older people
4. Pregnancy shouldnt be dissuaded in older age
5. Cholesterol-lowering therapy benefits older people also
6. New back support device can improve balance for older people
7. Do not regret growing older, It is a privilege denied to many
8. Womb Cancer , A cause for worry among older women
9. Cognitive deterioration in the older generation can be prevented by modifying the lifestyle
10. The older generation today, better off then predecessors.
11. First time mothers are older now
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... 2017 , ... Osteitis pubis may be commonplace and seemingly ... occurs when the muscles around the pelvis become inflamed. Over time, untreated osteitis ... as well as accompanying tenderness and weakness. Without proper intervention, it can hinder ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: